Advanced Tumor
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours (NCT05607563) | Biotheus Inc. | 2022-11-21 |
| Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors (NCT05839106) | Biotheus Inc. | 2022-07-08 |
| QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors (NCT05108779) | Qilu Pharmaceutical Co., Ltd. | 2021-11-09 |
| To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors (NCT06558513) | Evopoint Biosciences Inc. | 2021-08-03 |
| Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors. (NCT02977156) | Centre Leon Berard | 2017-01-03 |
| Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer (NCT00502060) | AstraZeneca | 2004-08-01 |
Track Advanced Tumor automatically
Every clearance here is in the API, with alerts when new ones post.